NFKB1 and neoplasm: Nonetheless, this review provides valuable molecular insights into the repositioning of drugs showing promise in targeting tumours with dysregulated Hippo and Wnt/β-catenin pathways, while also highlighting the importance of drug repurposing in alternative signalling pathways that are associated with tumourigenesis such as the NF-κB pathway.